Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
834,731,296
-
Total 13F shares
-
22,552,672
-
Share change
-
+1,830,496
-
Total reported value
-
$1,508,022,257
-
Put/Call ratio
-
2.9%
-
Price per share
-
$66.87
-
Number of holders
-
212
-
Value change
-
+$123,782,702
-
Number of buys
-
117
-
Number of sells
-
72
Institutional Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q3 2023
As of 30 Sep 2023,
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) was held by
212 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,552,672 shares.
The largest 10 holders included
BlackRock Inc., Royal Bank of Canada, GOLDMAN SACHS GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Robeco Institutional Asset Management B.V., VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, Man Group plc, MORGAN STANLEY, and GQG Partners LLC.
This page lists
212
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.